Essayer OR - Gratuit
Role of global pharma industry in TB diagnostics - II
Chronicle Pharmabiz
|August 21, 2025
IN the first part of this article, the authors described the TB remains a persistent global health challenge, particularly in lowand middle-income countries, and the global pharma industry has been at the forefront of TB diagnostics. In this concluding part, they are discussing about traditional sample transportation methods, DBS and dried sputum technologies, advanced molecular transport media & impact on TB diagnostics and public health.
Traditional sample transportation methods
Historically, TB sample transportation has relied heavily on conventional methods, such as cold chain systems, where samples are kept refrigerated or frozen during transit. This method is effective in preserving the viability of samples, particularly for sputum and other biological materials that are prone to degradation at room temperature. However, maintaining a cold chain can be challenging, especially in remote or resource-limited areas where access to electricity and reliable refrigeration is limited.
Strengths
Preserves sample integrity: Cold chain systems are effective in maintaining the viability of TB samples, which is crucial for accurate diagnostic results.
Widely adopted: Cold chain logistics are well-established and commonly used across various medical and research fields, making them a standard practice in TB sample transportation.
Limitations
Logistical challenges: Maintaining a cold chain requires reliable infrastructure, including continuous power supply and proper storage facilities, which may not be available in remote areas.
High costs: The need for refrigeration, specialized packaging, and temperature monitoring increases the overall cost of transportation, making it less feasible for widespread use in low-income regions.
Limited reach: Cold chain-dependent solutions are less accessible in regions with poor infrastructure, limiting their effectiveness in those areas most affected by TB.
DBS and dried sputum technologies
To address the challenges of cold chain logistics, alternative methods such as Dried Blood Spot (DBS) and dried sputum technologies have been developed. These methods involve collecting samples on specially treated paper, which allows them to be dried and stored at room temperature for extended periods.
Cette histoire est tirée de l'édition August 21, 2025 de Chronicle Pharmabiz.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Chronicle Pharmabiz
Chronicle Pharmabiz
Miltenyi Biotec, THSTI to set up cell mfg programme
IN a milestone step toward strengthening India's cell and gene therapy (CGT) ecosystem, Miltenyi Biotec, a global leader in CGT technologies, has signed a Letter of Intent (LOI) with the Translational Health Science and Technology Institute (THSTI) to establish India's first hands-on training programmes in clinical cell manufacturing.
1 min
August 21, 2025
Chronicle Pharmabiz
MDC asks Abbott Healthcare to avoid negligence while filing price details
THE Multi Disciplinary Committee (MDC) of Experts, which advises the National Pharmaceutical Pricing Authority (NPPA) on pricing matters, has directed Abbott Healthcare to avoid negligence in filing proper details while submitting the price related details in the Integrated Pharmaceutical Database Management System (IPDMS).
1 mins
August 21, 2025
Chronicle Pharmabiz
Greenspace Herbs unveils 'Quantum Ayurveda'
GREENSPACE Herbs, a leading botanical ingredients company, announced the commercial launch of Quantum Ayurveda, an advanced technology platform that enhances traditional herbal ingredients using quantum resonance principles.
1 min
August 21, 2025

Chronicle Pharmabiz
Gandhi Automations ensuring clean room integrity with high-speed doors
GANDHI Automations Pvt Ltd offers prime clean reset high-speed doors to ensure clean room integrity, minimize air permeability and leakages.
3 mins
August 21, 2025
Chronicle Pharmabiz
Haryana DC officials raid unregistered clinic in Karnal
In a swift response to a complaint regarding illegal medical practice, a team of health and drug control officials raided an unregistered clinic in Karnal in Haryana, leading to the arrest of an individual found to be practicing medicine without proper medical qualification.
1 min
August 21, 2025
Chronicle Pharmabiz
Guj attracts investments from 100 cr to 5,000 cr
GUJARAT has attracted big ticket investments from MNCs and Indian companies as part of 376 Memorandum of Understandings (MoUs) ranging from Rs. 100 crore to Rs. 5,000 crore, informed Dr H G Koshia, Commissioner of the Gujarat Food & Drug Control Administration (FDCA).
1 min
August 21, 2025
Chronicle Pharmabiz
'Industry's diversification to EU markets is acting as a buffer against US trade shocks'
INDIAN Pharma industry's diversification into European markets is acting as a buffer against US trade shocks, says Parag Bhatia, director, Laborate Pharmaceuticals.
2 mins
August 21, 2025
Chronicle Pharmabiz
Pharma, CROs turn to hybrid cloud infra to safeguard patient information
PHARMA companies and clinical research organizations (CROs) are increasingly adopting hybrid cloud infrastructure to safeguard sensitive patient information.
2 mins
August 21, 2025
Chronicle Pharmabiz
'India's PLI scheme transforms pharma industry from policy to practice'
INDIA'S production linked incentive (PLI) scheme has emerged as a transformative policy aimed at revitalizing the pharmaceutical sector and its global competitiveness.
2 mins
August 21, 2025
Chronicle Pharmabiz
CDSCO cancels Proteos' Indian agent's import regn
THE Cosmetics Division of the Central Drugs Standard Control Organisation (CDSCO) has cancelled the registration certificate of NKG Advisory Business and Consulting Services to sell the cosmetic products of Spanish cosmetics maker Proteos Biotech, based on the former's request.
1 min
August 21, 2025
Listen
Translate
Change font size